NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

FDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Infection Prevention

PDUFA date set for Nov 28, 2026, triggering $15M milestone.

FDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Infection Prevention
Credit: Unsplash/Husien Bisky
Already have an account? Sign in.
07/29/2026 · 9:56 AM
PYPD
/ Don’t stop at just one post.

Related↓

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada
07/21/2026 · 3:53 PM

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada

Roth Capital maintains a Buy rating with a $9 price target despite the post-deal share decline.

/ Subscriber only
/ Read more

Feed↓

FDA Alignment De-Risks CalciMedica’s Auxora Path in Acute Pancreatitis
07/29/2026 · 11:28 AM

FDA Alignment De-Risks CalciMedica’s Auxora Path in Acute Pancreatitis

FDA aligns with CalciMedica on Auxora Phase 2b endpoints for acute pancreatitis, de-risking the path to registration.

/ Subscriber only
Garmin Raises Full-Year Outlook After Strong Wearables Demand in Q2
07/29/2026 · 11:16 AM

Garmin Raises Full-Year Outlook After Strong Wearables Demand in Q2

Garmin raises full-year targets to $8.05B revenue and $10 EPS after Q2 sales hit $2.02B, led by 25% fitness growth from wearables demand.

/ Subscriber only
Data Centers Power Generac’s Q2 Beat: Sales Up 11%, Margins Surge
07/29/2026 · 9:24 AM

Data Centers Power Generac’s Q2 Beat: Sales Up 11%, Margins Surge

Generac secures a second global supply deal with a hyperscale data center customer, lifting its backlog to $1.6B and powering strong Q2 growth.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe